archives - 過去の開催
The 4th - 2017
The 3rd - 2016
The 2nd - 2015
The 1st - 2014

As global economic growth brings about large increase of human and logistical mobility, taking effective measures against the threat of communicable diseases has become one of the most important challenges for not only a country, but also for the international society.

Under such circumstance, Nikkei Inc. has been organizing the annual Nikkei Asian Conference on Communicable Diseases since 2014, gathering internationally renowned experts in the area, both within and outside Japan, representatives of the private sector, and high-ranking government officials responsible for health.
Conference participants reaffirmed the imminent threat posed by communicable disease and the importance of stepping up efforts to address such threat, agreeing that Japan has a significant role to play in the fight against communicable disease in Asia and worldwide.

Through the open discussions among government, industry, and academia, the conference not only proposes concrete and practical action plans, but also works closely throughout the year to implement such action plans by establishing a consortium that accompanies the statement. One ideal examples are TB Consortium and Malaria Consortium, that take forms of PDPs (Product Development by Public Private Partnership) to bring into the world Japan’s diagnostic and treatment technologies that contribute to elimination of multidrug-resistant tuberculosis and malaria.

The 5th Nikkei Asian Conference on Communicable Diseases is to be held on 2nd-3rd, February, 2018 in Okinawa. The fruits of the conference will be disseminated around the world through Nikkei’s diverse media network, driving the momentum further on.





Overview - 開催概要

日 時
February 2(Fri.) - 3(Sat.),2018
会 場
Okinawa Convention Center
主 催
Nikkei Inc.
Nikkei Business Publications, Inc., Nikkei Medical Publishing, Inc.
In association with
協 力
Okinawa Prefecture
Official Support
後 援
Ministry of Economy, Trade and Industry; Ministry of Education, Culture, Sports, Science and Technology; Ministry of Foreign Affairs; Ministry of Health, Labour and Welfare
協 賛

Sponsors with lunch / breakout session 特別協賛(ランチセッション / 分科会開催)

FUJIFILM Corporation, TOYAMA CHEMICAL CO., LTD., neopharma Japan Co., Ltd., DAIICHI SANKYO CO.,LTD., Saraya Co., Ltd., SHIONOGI & CO., LTD., Sumitomo Chemical Company, Limited, SYSMEX CORPORATION

富士フイルム・富山化学工業、 ネオファーマジャパン、 第一三共、 サラヤ、 塩野義製薬、 住友化学、 シスメックス

Sponsors 協賛

Eiken chemical co.,ltd., Global Health Innovative Technology Fund (GHIT Fund), Mitsubishi Tanabe Pharma Corporation, NIPRO CORPORATION, Takeda Pharmaceutical Company Limited, Sumitomo Dainippon Pharma Co., Ltd., UNITAID

栄研化学、 グローバルヘルス技術振興基金(GHIT Fund)、 田辺三菱製薬、 ニプロ、 武田薬品工業、 大日本住友製薬、 ユニットエイド
Admission Fee
Free Admission (Pre-registration/Selection)
Seats are limited. Seminar attendees will be selected by the organizer. All applicants (whether selected or not) will be notified via email. Registration will be closed Mon January 15 9:30am.
※尚、本会議の受講申し込みは、2018年1月15日(月) 9:30AMまでにご登録ください。

Seminar Registration - セミナー申し込み


nikkei 日経BP社 日経メディカル開発ロゴ 沖縄県

Sponsors with lunch / breakout session

富士フィルム 富山化学工業 ネオファーマジャパン
第一三共 サラヤ 塩野義製薬 住友化学 シスメックス


Eiken chemical co.,ltd. Global Health Innovative Technology Fund (GHIT Fund) Mitsubishi Tanabe Pharma Corporation
 NIPRO CORPORATIONTakeda Pharmaceutical Company Limited
Sumitomo Dainippon Pharma Co., Ltd.UNITAID